Delivery Order SPE2DB20D1109-SPE2DB24FP40P

Award Date 6/27/24
Potential Completion Date 6/28/24
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,557.66 firm fixed-price contract is for the delivery of Levorphanol Tablets 2mg, a specialty medication, with a performance period through May 17, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,202,532 units of the prescription medication Levorphanol 2 mg tablets in quantities of 100 per bottle. The contract has a firm fixed price of $1,984.51 and a completion date of May 12, 2025. This award is not associated with a set-aside program and appears to be an...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,860.82, is a delivery order for 4,568,150,902 tablets of the medication Levorphanol 2 mg. The contract has a completion date of May 7, 2025 and uses a firm fixed price pricing type. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp is a for-profit organization that...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the delivery of 2 mg levorphanol tablets. The contract has a ceiling value of $3,534.93 and an ultimate completion date of March 24, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,019.52 firm fixed-price delivery order is for the supply of 4564437604 LEVORPHANOL 2 MG TABLET 100S, with a performance period through April 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,509.26 to Amerisourcebergen Drug Corporation for 100 tablets of 2 mg levorphanol. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order period of performance is August 7-8, 2023. Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to the Defense Logistics Agency under this small purchase order as a division of its parent company,...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $13,503.14 firm fixed-price delivery order by the Defense Logistics Agency Troop Support Medical to supply 4561966059 Levorphanol tabs 2mg. The single delivery order is for a one-day period of performance from August 28-29, 2023 at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The Defense Logistics Agency Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,950.62 firm fixed-price delivery order is for the supply of 4,564,730,312 units of levetiracetam 500 mg tablets. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Medical Supply Chain unit of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $7,414.06 fixed-price contract is for the supply of the pharmaceutical product Levonorgestrel 1.5 mg. The award does not have a set-aside designation. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, has been issued an Indefinite Delivery Contract (IDC)...
This is a $1,209.54 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The contract provides for the supply of Levonorgestrel 1.5 mg tablets, a pharmaceutical product, with an ultimate completion date of August 26, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans' hospitals, and other federal...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP40P
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,457.04, is for the supply of Levorphanol 2 mg tablets. The order was placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. The award demonstrates AmerisourceBergen's extensive experience and capabilities in supplying critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to various federal agencies and military healthcare programs.

Generated 2/27/25, 12:30 PM